BCHE and hematologic disorder: Considering only the patients who underwent allogenic HSCT for hematologic malignancies, BChE activity value ≤ 1799 U/L maintained a good predictive performance for severe liver damage with AUC = 0.761 and 95% CI = 0.673–0.835 (p < 0.001), sensitivity 63.2% and specificity 84.7%.